News
Advertisement
Advertisement
Evolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity.
Advertisement
Advertisement
The latest industry happenings from the past month, all in one place.
87% of people surveyed said they had no concerns about a decentralized approach to clinical trials.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
2
ACT Brief: AI in Clinical Research, FDA Gene Therapy Approval, and High-Performing Hospital Partnerships
3
Investigative Site Investment, Preparedness, and Experience with Digital Solutions
4
How AI, Automation, and FSP Partners Are Reshaping Global Pharmacovigilance
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
